PREMIER BIOMEDICAL INC

Type: Company
Name: PREMIER BIOMEDICAL INC
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Lamperd Less Lethal Eliminates Margin of Error for Police

/ Shortly after 18-year old Michael Brown was fatally shot, St. Louis police officers responded to a crime just 25 miles away and fatally shot 25-year old Kajieme Powell after he approached officers with a knife. Police managed to calm the crowds but ... [Published 4 Traders - Aug 26 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Premier Biomedical Announced the Addition of Dr David Vigerust to Their Scientific Advisory Board

El Paso, Texas, Aug. 18, 2014 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC-BB: "BIEI") announced theaddition of Dr David Vigerust to their Scientific AdvisoryBoard  effective immediately. Dr Vigerust will report to theChairman of the Scientific  ... [Published Town Hall - Aug 18 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 3 reports

Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia

EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia ... [Published EON Science - Jun 30 2014]
First reported Jun 17 2014 - Updated Jun 17 2014 - 3 reports

Premier Biomedical Releases Anti-CTLA4 Market Study

EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical Releases Anti-CTLA4 Market Study. Premier Biomedical Inc. (OTCBB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune system manipulation. ... [Published EON Science - Jun 17 2014]
First reported May 08 2014 - Updated May 08 2014 - 5 reports

Premier Biomedical Enters Into Discussions with DOD to Initiate Staged Clinical Trials for Possible Head Trauma Cure

Premier Biomedical, Inc. (OTCBB: “BIEI”) a biopharmaceutical companyfocused on developing and commercializing innovative treatment therapiesfor cancer , traumatic brain injury, Alzheimer’s disease, and otherafflictions announced today that they have initiated ... [Published BioPortfolio - May 08 2014]
First reported Apr 24 2014 - Updated Apr 24 2014 - 4 reports

Premier Biomedical Receives Notice of Allowance on Broad Base Patent

Premier Biomedical, Inc. (OTCBB:BIEI) a biopharmaceutical companyfocused on developing and commercializing innovative immune-systemmanipulation therapies for breast cancer , as well as potential noveltherapies for Alzheimer ’s disease, multiple sclerosis ... [Published BioPortfolio - Apr 24 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 3 reports

Premier Biomedical’s CEO Invited to Speak at Brewer Sports Symposium V Featuring High-Level Executives and Industry Leaders Spanning Professional Sports

EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical’s CEO Invited to Speak at Brewer Sports Symposium V Featuring High-Level Executives and Industry Leaders Spanning Professional Sports ... [Published EON Science - Apr 10 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 3 reports

Premier Biomedical Continues Progress on Anti-Cancer Treatment

EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical Continues Progress on Anti-Cancer Treatment. ... [Published EON Science - Apr 02 2014]
First reported Mar 26 2014 - Updated Mar 27 2014 - 5 reports

Premier Biomedical Signs Agreement To Design Equipment For Clinical Trials

EL PASO, Texas--(EON: Enhanced Online News)--"BIEI" signs agreement on patent pending device for use with revolutionary technology for clinical trials. ... [Published EON Consumer - Mar 26 2014]

Quotes

More Content

All (31) | News (4) | Reports (0) | Blogs (27) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Lamperd Less Lethal Eliminates Margin of Error ... [Published 4 Traders - Aug 26 2014]
Premier Biomedical Announced the Addition of Dr... [Published Town Hall - Aug 18 2014]
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published EON Science - Jun 30 2014]
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published Business Wire Science: Science News - Jun 30 2014]
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published Business Wire Health News - Jun 30 2014]
Premier Biomedical Releases Anti-CTLA4 Market S... [Published EON Science - Jun 17 2014]
Premier Biomedical Releases Anti-CTLA4 Market S... [Published Business Wire Science: Science News - Jun 17 2014]
Premier Biomedical Releases Anti-CTLA4 Market S... [Published Business Wire Health News - Jun 17 2014]
Premier Biomedical Enters Into Discussions with... [Published BioPortfolio - May 08 2014]
Premier Biomedical Enters Into Discussions with... [Published EON Science - May 08 2014]
Premier Biomedical Enters Into Discussions with... [Published Business Wire Science: Science News - May 08 2014]
Premier Biomedical Enters Into Discussions with... [Published Business Wire Defense News - May 08 2014]
Premier Biomedical Enters Into Discussions with... [Published Business Wire Health News - May 08 2014]
Premier Biomedical Receives Notice of Allowance... [Published BioPortfolio - Apr 24 2014]
Premier Biomedical Receives Notice of Allowance... [Published EON Science - Apr 24 2014]
Premier Biomedical Receives Notice of Allowance... [Published Business Wire Science: Science News - Apr 24 2014]
Premier Biomedical Receives Notice of Allowance... [Published Business Wire Health News - Apr 24 2014]
Premier Biomedical’s CEO Invited to Speak at Br... [Published EON Science - Apr 10 2014]
Premier Biomedical’s CEO Invited to Speak at Br... [Published Business Wire Science: Science News - Apr 10 2014]
Premier Biomedical’s CEO Invited to Speak at Br... [Published Business Wire Health News - Apr 10 2014]
Premier Biomedical Continues Progress on Anti-C... [Published EON Science - Apr 02 2014]
Premier Biomedical Continues Progress on Anti-C... [Published Business Wire Science: Science News - Apr 02 2014]
Premier Biomedical Continues Progress on Anti-C... [Published Business Wire Health News - Apr 02 2014]
Premier Biomedical Signs Agreement To Design Eq... [Published EON Consumer - Mar 26 2014]
Premier Biomedical Signs Agreement To Design Eq... [Published EON Science - Mar 26 2014]
Premier Biomedical Signs Agreement To Design Eq... [Published Business Wire Science: Science News - Mar 26 2014]
Premier Biomedical Signs Agreement To Design Eq... [Published Business Wire Technology News - Mar 26 2014]
Premier Biomedical Signs Agreement To Design Eq... [Published Business Wire Health News - Mar 26 2014]
Premier Biomedical to Present Positive Pre-Clin... [Published Marketwire - Breaking News Releases - Feb 26 2014]
Premier Biomedical Met With NFL and NCAA Repres... [Published Marketwire - Breaking News Releases - Feb 13 2014]
1 2
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published EON Science - Jun 30 2014]
EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia ...
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published Business Wire Science: Science News - Jun 30 2014]
EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia ...
Premier Biomedical, Inc. (BIEI) Announces Impor... [Published Business Wire Health News - Jun 30 2014]
EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia ...
Premier Biomedical Releases Anti-CTLA4 Market S... [Published EON Science - Jun 17 2014]
EL PASO, Texas--(EON: Enhanced Online News)--Premier Biomedical Releases Anti-CTLA4 Market Study. Premier Biomedical Inc. (OTCBB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune system manipulation. ...
Premier Biomedical Releases Anti-CTLA4 Market S... [Published Business Wire Science: Science News - Jun 17 2014]
EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical Releases Anti-CTLA4 Market Study. Premier Biomedical Inc. (OTCBB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune system manipulation. ...
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.